Left at Year-End,” Wall Street Journal, February 16, 2017.On February 4, 2014, Partner Fund: Partner Investments, L.P. et al. v.
Theranos, Inc. et al. complaint, 17–18.
- THE GRANDSON
It was as if you flipped a coin enough times: Partner Investments, L.P., PFM
Healthcare Master Fund, L.P., PFM Healthcare Principals Fund, L.P. v.
Theranos, Inc., Elizabeth Holmes, Ramesh Balwani and Does 1-10, No.
12816-VCL, Delaware Chancery Court, deposition of Tyler Shultz taken on
March 6, 2017, in San Francisco, California, 138.
Over a period of several days: Email with the subject line “RE: Follow up to
previous discussion” sent by Tyler Shultz to Elizabeth Holmes at 3:38 p.m.
PST on April 11, 2014.
Moreover, Do wasn’t even authorized: Partner Investments, L.P. et al. v.
Theranos, Inc. et al., deposition of Erika Cheung taken on March 7, 2017, in
Los Angeles, California, 45–47.
The inspector spent several hours: CMS Form 2567 indicating that relatively minor
deficiencies were found during an inspection of Theranos’s laboratory on
December 3, 2013.
It could be widened at will: Tyler Shultz’s April 11, 2014, email to Elizabeth
Holmes.
One of them was Elizabeth’s: Joseph Rago, “Elizabeth Holmes: The Breakthrough
of Instant Diagnosis,” Wall Street Journal, September 7, 2013.
Tyler had looked up the CLIA regulations: Title 42 of the Code of Federal
Regulations, Part 493, Subpart H, Section 801.
At 9:16 a.m. on Monday: Email with the subject line “RE: Proficiency Testing
Question” sent by Stephanie Shulman to Colin Ramirez, aka Tyler Shultz, at
12:16 p.m. EST on March 31, 2014.
In response to a description he gave her: Email with the subject line “RE:
Proficiency Testing Question” sent by Stephanie Shulman to Colin Ramirez,
aka Tyler Shultz, at 4:46 p.m. EST on April 2, 2014.
So he went ahead and typed up: Tyler Shultz’s April 11, 2014, email to Elizabeth
Holmes.
In a point-by-point rebuttal: Email sent by Sunny Balwani to Tyler Shultz on April
15, 2014.
It said she disagreed with running: Resignation letter written by Erika Cheung